Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate versus cyclosporine for lichen planopilaris
IRCT20190717044256N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in lichen planopilaris (LPP) comparing Methotrexate with Cyclosporine (2 arms). Primary endpoint: Lichen planopilaris activity index. Started Sep 2017; status: completed.
02
Drugs
methotrexatecyclosporine
03
Conditions
lichen planopilaris (LPP)
Beyond the preview
Go deeper on IRCT20190717044256N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190717044256N1.